Texts and home visits aim to stop repeat STIs in young women
NCT ID NCT03828994
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a program combining daily text reminders, nurse home visits, and field-based treatment can help young women (ages 13-25) avoid repeat sexually transmitted infections after being treated for pelvic inflammatory disease (PID). The 150 participants in Baltimore will receive extra support for 30 days. Researchers hope this approach will improve treatment adherence and reduce risky sexual behavior.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
text messaging and community health nurse visits
What this could lead to
If it works, this could offer a cost-effective way to reduce repeat infections and improve vaginal health in young women after PID.
What could go wrong
This is a small, early-stage behavioral study, not a drug trial. Results may not apply to other cities or populations, and adherence to the program may vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PELVIC INFLAMMATORY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins School of Medicine
Baltimore, Maryland, 21287, United States